A metagene of NRF2 expression is a prognostic biomarker in all stage colorectal cancer
S. O'Cathail, C.-H. Wu, A. Lewis, C. Holmes, M. Hawkins, T. S. Maughan
The paper defines an NRF2 metagene and shows it predicts poor prognosis in all stages of colorectal cancer, with higher expression in CMS4 subtype.
bioRxiv · Jul 2, 2019 · PreprintCancer Biology